Patent details
EP3679046
Title:
PHOSPHAPLATIN COMPOUNDS AS IMMUNO-MODULATORY AGENTS AND THERAPEUTIC USES THEREOF
Basic Information
- Publication number:
- EP3679046
- PCT Application Number:
- US2018049980
- Type:
- European Patent Granted for LU
- Legal Status:
- Unitary Effect Registered
- Application number:
- EP188528574
- PCT Publication Number:
- WO2019051246
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- PHOSPHAPLATIN COMPOUNDS AS IMMUNO-MODULATORY AGENTS AND THERAPEUTIC USES THEREOF
- French Title of Invention:
- COMPOSÉS DE PHOSPHAPLATINE UTILISÉS EN TANT QU'AGENTS IMMUNOMODULATEURS ET LEURS UTILISATIONS THÉRAPEUTIQUES
- German Title of Invention:
- PHOSPHAPLATIN-VERBINDUNGEN ALS IMMUNMODULATORISCHE MITTEL UND IHRE THERAPEUTISCHE VERWENDUNG
- SPC Number:
-
Unitary Effect
- Unitary Effect Requested:
- Yes
- Unitary Effect Request Filing Date:
- 08/12/2023
- Link to UPP Register:
-
European Patent Register
- Unitary Effect Request Withdrawal Date:
-
- Unitary Effect Status:
- Unitary Effect Registered
- Unitary Effect Acceptance Decision Date:
- 24/01/2024
- Unitary Effect Rejection Decision Date:
-
- Unitary Effect Date:
- 08/11/2023
- Unitary Effect Registration Date:
- 24/01/2024
- Unitary Effect Re-establishment of rights Filing Date:
-
- Unitary Effect Re-establishment of rights EPO Decision :
-
- Unitary Effect Re-establishment of rights EPO Decision Date:
-
- Explanatory Text UE:
-
- Safety Net Request Date:
- Safety Net Decision Date:
- Safety Net Decision Outcome:
- SPC Number:
-
Dates
- Filing date:
- 07/09/2018
- Grant date:
- 08/11/2023
- EP Publication Date:
- 15/07/2020
- PCT Publication Date:
- 14/03/2019
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 08/11/2023
- EP B1 Publication Date:
- 08/11/2023
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 07/09/2038
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 01/11/2023
-
-
- Name:
- Promontory Therapeutics Inc.
- Address:
- 1350 Ave. of the Americas, 23rd Fl., New York, NY 10019, United States (US)
Inventor
1
- Name:
- PRICE, Matthew
- Address:
- United States (US)
2
- Name:
- AMES, Tyler
- Address:
- United States (US)
Priority
- Priority Number:
- 201762555676 P
- Priority Date:
- 08/09/2017
- Priority Country:
- United States (US)
Classification
- IPC classification:
-
A61K 31/675;
C07F 15/00;
A61K 33/24;
A61P 35/00;
A61K 39/39;
A61K 39/00;
A61K 45/06;
Publication
European Patent Bulletin
1
- Issue number:
- 202345
- Publication date:
- 08/11/2023
- Description:
- Grant (B1)
2
- Issue number:
- 202403
- Publication date:
- 17/01/2024
- Description:
- Unitary Effect Request Receipt
3
- Issue number:
- 202409
- Publication date:
- 28/02/2024
- Description:
- Unitary Effect Request Acceptance
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |